![]() |
|
|
|
Postpone to July Plenary An attempt was made by Mr Lechner and colleagues in the PPE Group to postpone the vote on the Directive until the July Plenary. This was defeated by 161 to 387 with 15 abstentions Legal base The challenge to the legal base was rejected by 131 to 414 with 23 abstentions Recitals Most (but not all) of the new recitals proposed by the Environment Committee at their meeting on 25th May were accepted – some in slightly strengthened format. These cover: the age of onset of smoking by young people; harm reduction claims; WHO FTC negotiations; establishment of a Tobacco Control Working Group (to provide expert advice to the Commission); provisional use of ISO standards; prohibition of ammonia; the risks of passive smoking, especially to children; toxins research; and the creation of a Regulatory Committee. Articles
General
The Commission’s proposals have not been altered by the Parliament. Maximum authorised yields are therefore: Tar 10 mg; Nicotine 1 mg; Carbon Monoxide 10 mg; with effect from 31 Dec 2003 There has been no change to the Commission text in terms of the derogation currently allowed to Greece. Greece does not have to introduce the tar limit of 10 mg until Dec 2006. This derogation does not apply to limits on nicotine and carbon monoxide. Member States other than Sweden may not permit the marketing of tobacco for oral use. This derogation was obtained by Sweden during accession negotiations before Sweden joined the EU. There had been heavy lobbying to remove the ban, i.e., to liberalise the market for SNUS throughout the EU. This did not succeed. On 25th May, the Environment Committee supported an amendment that would have allowed Member States to authorise the use of pictures to illustrate health warnings, along the lines about to be introduced in Canada. This proposal was overturned in Plenary. There had been considerable lobbying by the industry and employees’ organisations to remove exports from the scope of the Directive. This failed. The only concession was an extension for the implementation of this aspect of the Directive to Dec 2006, to give the industry time to adapt. European Parliament support The European Parliament was newly elected in June 1999. It was impossible to gauge how much support a measure like this would command in the new Parliament. The first indication came in the first vote, i.e., the attempt by some members to postpone consideration to July. There are 626 MEP’s. More than 560 Members attended throughout the vote, and voted one way or another (or abstained) on a total of 120 amendments. More than 20 votes were taken on the basis of a ‘roll call’, i.e., we can identify which way individual MEP’s voted on these particular amendments. Otherwise, many of the amendments were taken on a show of hands, and some were counted (using electronic voting). It is obvious that pro-health amendments received more support than ‘pro-industry’ amendments (these were largely to delay or minimise the effect of various aspects of the Commission proposal); but it is difficult to be precise on numbers. Crudely, the pro-health arguments seemed to be supported by about two thirds of MEP’s. At the end of all the votes, the Maaten report, as amended, was put to the vote. It was adopted on a show of hands; as was the subsequent legislative resolution. NB: The Parliament does not have the final say. The Parliament has authority of co-decision with the Council. Attention now shifts to the meeting of the Health Council, to be held on Thurs, 29th June.
AH/BXL/15.vi.00 |